Cheatography
https://cheatography.com
Drugs for HF (Module 2 - Pharmacology)
This is a draft cheat sheet. It is a work in progress and is not finished yet.
ACE INHIBITORS
PROTOTYPE DRUG |
lisinopril (Prinivil, Zestril) |
|
Drug of choice for HF |
Reduce afterload |
Increases cardiac output |
Enhance excretion of sodium and water |
- Lowers peripheral resistance and reduces blood volume |
|
PRIMARY USE: |
To decrease BP and reduce blood volume; dilate veins |
|
ADVERSE EFFECTS: |
- First-dose hypotension - Cough - Hyperkalemia - Renal failure |
ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs)
END IN |
"-SARTAN" |
PROTOTYPE DRUG: |
candesartan (Atacand) |
|
Actions very similar to ACE inhibitors |
Usually used for pts who are unable to tolerate ACE inhibitors |
|
PRIMARY USE: |
HTN and HF (for those who can't tolerate ACE inhibiitors) |
|
ADVERSE EFFECTS: |
|
Hypotension Hyperkalemia |
|
PATIENT TEACHING: |
Sodium & potassium restrictions Contraception |
|
|
DIURETICS
PROTOTYPE DRUG |
furosemide (Lasix) |
Increase urine flow |
Reduce |
- blood volume and cardiac workload - Edema and pulmonary congestion |
Prescribed in combination with other drugs |
|
PRIMARY USE: |
Diuretic |
|
ADVERSE EFFECTS: |
- Electrolyte imbalances - Hypovolemia - Orthostatic hypotension |
CARDIAC GLYCOSIDES
PROTOTYPE DRUG |
digoxin (Lanoxin) |
|
Increase forcec of heartbeat, slow heart rate |
Improve cardiac output |
Second-line treatment for HF |
Narrow therapeutic range |
|
PRIMARY USE: |
To increase contractility or strength of myocardial contraction |
|
ADVERSE EFFECTS: |
- Neutropenia - Dysrhythmias - Digital toxicity |
|
|
Beta-Adrenergic Blockers "-olol" (Antagonists)
PROTOTYPE DRUG |
metoprolol (Lopressor, Troprol XL) |
|
Slow HR and reduce BP |
(Negative) inotropic effect |
Reduce workload of heart |
|
PRIMARY USE: |
- Reduce symptoms of HF - Slow progression of disease |
|
ADVERSE EFFECTS: |
- Fluid retention - Worsening of HF - Fatigue - Hypotension - Bradycardia - Heart block |
PHOSPHODIESTERASE INHIBITORS
PROTOTYPE DRUG |
milrinone (Primacor) |
|
Block enzyme phospho diesterase |
Increase calcium for myocardial contraction |
Cause positive inotropic response and vasodilation |
Increase contractility & decrease afterload |
Short-term therapy only |
|
PRIMARY USE: |
As a short term therapy for HF |
|
ADVERSE EFFECTS: |
- Hypokalemia - Hypotension - Ventricular dysrhythmias |
|
|
DIRECT VASODILATORS
PROTOTYPE DRUG: |
hydralazine (Apresoline) Sometimes used in combination with isosorbide dinitrate (Isordil) |
|
. |
PRIMARY USE: |
|
- Antihypertensive - Treatment of hypertensive crisis |
ADVERSE EFFECTS: |
|
- Stopping abruptly can cause rebound HTN - Flushing - Reflex tachycardia - Palpatations - Lupus-like reaction - Hypotension |
|
CONTRAINDICATED IN THOSE WITH: - Tachycardia - Angina - Rheumatic heart disease |
|